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Abstract
Background: Nuclear myosin I (NM1) is a nuclear isoform of the well-known ‘‘cytoplasmic’’ Myosin 1c protein (Myo1c).
Located on the 11th chromosome in mice, NM1 results from an alternative start of transcription of the Myo1c gene adding
an extra 16 amino acids at the N-terminus. Previous studies revealed its roles in RNA Polymerase I and RNA Polymerase II
transcription, chromatin remodeling, and chromosomal movements. Its nuclear localization signal is localized in the middle
of the molecule and therefore directs both Myosin 1c isoforms to the nucleus.
Methodology/Principal Findings: In order to trace specific functions of the NM1 isoform, we generated mice lacking the
NM1 start codon without affecting the cytoplasmic Myo1c protein. Mutant mice were analyzed in a comprehensive
phenotypic screen in cooperation with the German Mouse Clinic. Strikingly, no obvious phenotype related to previously
described functions has been observed. However, we found minor changes in bone mineral density and the number and
size of red blood cells in knock-out mice, which are most probably not related to previously described functions of NM1 in
the nucleus. In Myo1c/NM1 depleted U2OS cells, the level of Pol I transcription was restored by overexpression of shRNA-
resistant mouse Myo1c. Moreover, we found Myo1c interacting with Pol II. The ratio between Myo1c and NM1 proteins were
similar in the nucleus and deletion of NM1 did not cause any compensatory overexpression of Myo1c protein.
Conclusion/Significance: We observed that Myo1c can replace NM1 in its nuclear functions. Amount of both proteins is
nearly equal and NM1 knock-out does not cause any compensatory overexpression of Myo1c. We therefore suggest that
both isoforms can substitute each other in nuclear processes.
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Introduction
Myosins are unique proteins that have the ability to transform
free chemical energy stored in ATP into mechanical force. In
comparison to the well-known ‘‘conventional’’ class II myosins
found in muscles, there is a variety of other ‘‘unconventional’’
myosins belonging to several groups. Myosin I family members are
monomeric, non-processive, slow-rate and low-duty ratio molec-
ular motors. Myosin 1c (Myo1c) was the first single-headed myosin
isolated from mammals and it was therefore called mammalian
myosin I [1,2]. Based on its similarity to partial myosin sequence
from mouse cDNA library, it was later renamed as myosin 1b [3],
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and finally, after the unification of myosin I nomenclature, myosin
1c [4]. The human MYOIC gene encodes three isoforms. Myosin
1c isoform C is the classic 1063 amino acid ‘‘cytoplasmic’’ form
[2]. Myosin 1c isoform B, also known as nuclear myosin 1 (NM1),
includes 16 extra N-terminal amino acids arising from an
upstream exon -1 [5,6]. The newest isoform is myosin 1c, isoform
A, which includes additional 35 amino acids on its N-terminal end
from an upstream exon -2 and was described to work in the cell
nucleus [7]. In mice there have been only two myosin isoforms
described – Myo1c and NM1.
Myosin 1c (isoform C) belongs to a group of molecular motors
that link cellular membranes to the actin cytoskeleton, and are
involved in membrane tension generation, membrane dynamics,
and mechanosignal transduction. In detail, Myo1c was identified
to be associated with Neph1 and nephrin proteins. Myo1c
mediates their localization to the plasma membrane and its
depletion causes defects in tight junctions’ formation and cell
migration [8]. In the neuronal growth cone, Myo1c affects
lamellipodial motility and is responsible for retention of lamelli-
podia [9] and retrograde F-actin flow [10]. In Xenopus laevis,
Myo1c participates in egg activation by coupling dynamic actin to
the membranes of cortical granules, and this linkage is essential for
their compression and retrieval [11]. Insulin stimulates glucose
transport in adipocytes by promoting exocytosis of the population
of vesicles containing glucose transporter protein GLUT4. Myo1c
enhances exocytosis of GLUT4-containing vesicles to plasma
membrane [12,13]. The most extensively studied function of
Myo1c concerns the process of hearing. Sensory cells of the inner
ear detect sound and transmit signals representing those stimuli to
the central nervous system. Myo1c has a direct function in the
adaptation of sensory cells to sustained excitatory deflection, since
upon its inhibition the adaptation is slow and inefficient [14].
Moreover, clinical studies revealed 6 missense mutations in Myo1c
that were associated with bilateral hearing loss [15].
All these functions connect Myo1c to the plasma membrane
and actin filaments. This was further proved by Nambiar et al.
(2009) who showed that Myo1c together with other myosin I
family members mediate membrane/cytoskeleton adhesion. This
makes major contributions to membrane tension, which is one of
the main parameters needed in endo- and exocytosis, membrane
repair, cell motility, and cell spreading.
Nuclear myosin I (isoform B) was discovered coincidentally by
testing of affinity-purified polyclonal antibodies to adrenal myosin
1. The antibody was staining a 120-kDa nuclear protein with
ATPase activity, and ATP-, actin- and calmodulin- binding which
are the typical features of unconventional myosins [5]. The mass
spectrometric analysis of the immunopurified protein showed high
homology to the Myo1c protein. Due to the fact that at that time,
NM1 was the first myosin found in the cell nucleus, it was called
nuclear myosin I [6]. In the nucleus, NM1 associates with nuclear
actin and is required for RNA polymerase I (Pol I) and RNA
polymerase II (Pol II) transcription [6,16]. Both NM1 and actin
co-localize and co-immunoprecipitate with Pol I and Pol II
complexes. In vitro immunodepletion of NM1 inhibits transcription
by both polymerases and the addition of purified NM1 increases
the level of transcription in a dose-dependent manner. While both
proteins associate with Pol I, actin associates with Pol I regardless
of the transcriptional state. In contrast, NM1 only associates with
initiation-competent RNA polymerase I complexes through an
interaction with the basal transcription factor TIF1A [16]. In
addition to transcription initiation, NM1 is needed in further steps
during elongation phase where it interacts with chromatin
remodeling complex WSTF-SNF2h and facilitates Pol I transcrip-
tion on chromatin [17]. It is therefore believed that NM1 bound to
TIF-1A is recruited to the pre-initiation complex along with Pol I
and associated actin to assemble a functional transcription
initiation complex. Recruitment of Pol I to the NM1-TIF-1A
complex might facilitate the interaction of NM1 with actin bound
to Pol I. Finally, by interacting with NM1, chromatin remodeling
complexes join the initiation complex to promote Pol I movement
through chromatin [18]. This is also supported by the finding that
both actin polymerization and the motor function of NM1 are
required for association with the Pol I transcription machinery and
transcription activation [19]. Moreover, NM1 was found in
interaction with RNA and RNA-protein complexes present in the
nucleoplasm and in nucleoli [20]. It participates in the maturation
of pre-rRNA, and accompanies rRNA transcripts to the nuclear
pore where NM1 decorates actin-rich pore-linked filaments [21].
Aside from its functions in transcription, Chuang et al. (2006)
showed that the actin-NM1 complex is needed for long-range
directional movement of interphase chromosome sites indepen-
dently from their engagement in transcription. NM1 is also able to
bind DNA directly via its tail domain [22], and NM1 together with
gelsolin were identified as key determinants for assembling and/or
stabilization of complexes containing estrogen receptor a (ERa)
and actin in the nucleus early after receptor activation by its
ligands [23].
Both Myo1c and NM1 proteins are shown to be expressed in a
wide variety of tissues and cultured cell lines. Their expression
pattern is similar but not completely overlapping. Both proteins
have the highest level of expression in mouse lungs, followed by
intestine, kidney, heart and spleen for NM1, and adrenal gland,
stomach, spleen, heart and esophagus for Myo1c. These expres-
sion profiles suggested possible tissue-specific functions for both
proteins [2,24,25]. However, Myo1c is localized mostly at the cell
periphery and at the plasma membrane, particularly at the leading
edges of motile cells [2], while NM1 was described to localize
mostly in the nucleus where its distribution is dependent on
transcriptional activity of the cell [26,27]. The 16 amino acid N-
terminal extension of NM1 molecule was thought to be the
nuclear localization signal for this protein [6]. However, we
recently showed that nuclear localization signal which triggers
NM1 to the nucleus is located in the middle part of the molecule
and therefore direct both NM1 and Myo1c to the nucleus. This
novel calmodulin-dependent NLS is localized in the second of
three IQ domains [24]. Because of the various nuclear functions of
NM1, it is important to determine if both isoforms can perform
identical functions. We therefore prepared mice lacking NM1
isoform without affecting Myo1c expression and here we describe
observed phenotypes in NM1 knock-out mice. Surprisingly, these
mice were fully viable and did not show any obvious defects
related to previously described functions of NM1 in DNA
transcription. Moreover, the ratio between both isoforms in the
nucleus and cytoplasm is roughly equal. We therefore tested
Myo1c’s capability to act in transcription. We found that Myo1c is
able to functionally substitute NM1 in Pol I transcription.
Moreover, it directly binds to the Pol II CTD domain suggesting
it has also a role in Pol II transcription. In conclusion, we suggest
that the two isoforms Myo1c and NM1 (isoforms C and B) are
mutually redundant in general process of transcription.
Materials and Methods
Ethics statement
All animal experiments and work with human and mice cell
lines conformed to relevant regulatory standards and were
approved by the Ministry of Agriculture of the Czech Republic,
the ethic committee of the Institute of Molecular Genetics ASCR
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(animal experiment license no. 40/2009 and 186/2010) and the
district government of Upper Bavaria (Regierung von Ober-
bayern).
The project for the generation of the mutants was discussed and
approved by the institutional ethics committee of the Vedmeduni
Vienna and animal experiment license granted under no. BMWF-
68.205/0084-II/10b/2008. All animal experiments performed in
GMC were done with permissions of the appropriate authorities
according to the 18 of the German Law for the Protection of
Animals.
Plasmids
NM1-Fl and Myo1c-Fl vectors were prepared by cloning of
NM1 and Myo1c cDNA into pCDH-CMV-MCS-EF1-Neo
(Systems Bio) using SnaBI and EcoRI restriction enzymes in
frame with the C-terminal Flag tag. The constructs expressing
shRNA-resistant NM1-GFP and Myo1c-GFP was prepared by
excision of mouse NM1-GFP and Myo1c-GFP from vectors NM1-
GFP and Myo1c-GFP [24] and ligated into pCDH-EF1-Neo
(Systems Bio). The NM1-GFP construct has been previously
described [24].
Preparation of targeting construct for knock-out mice
For the preparation of conditional NM1 knock-out (KO), the
Cre–loxP system and a targeting construct based on pEasyFlox
vector was used [28].The short homology arm (SA, 0,9 kb) was
prepared by PCR amplification of genomic DNA sequence from -
1096 to -166 base pairs from NM1 translation initiation site using
primers SA F (59-gtagagtcgacTATGCCACAAGAGGTGG-
CAACT-39) and SA R (59-gccgaagcttCCGGGCTGGGTGG-
GAGGGGGTTCG-39). The long homology arm (LA, 1,7 kb)
was prepared by amplification of genomic DNA from +116 to
+1800 base pairs from the NM1 translation initiation site, using
primers LA F (59-ggggatccGGTGGAAGATGTCCCTGAA-
AGTTG-39) and LA R (59-gctgcggccgcGTAGTAACCTGGG-
CATTGCTGTCC-39). The floxed part encoding the -1 exon
(containing the NM1 start codon); (FP, 0,3 kb) was prepared by
amplification of genomic DNA from -165 to +115 base pairs from
the NM1 translation initiation site, using primers FP F (59-
cccagtcgacCCAGGCCGGCTGCAGTGGGTCCTA-39) and FP
R (59-catcttctagaGAAATTCCTGGGCCGCGCCCGCTT-39)
(Fig.1A). All PCR reactions were done using mouse 129/Sv
genomic DNA as a template. The SA PCR product was digested
and cloned into the pEasyFlox vector via XhoI and HindIII
restriction sites, LA by BamHI and NotI and FP via SalI and XbaI
restriction sites. For screening of positively electroporated cells
with the targeting construct, we used a neomycin-resistance
positive selection marker (Neo) flanked with loxP sites (Fig. 1B).
Generation of NM1 knock-out mice
To test the influence of the N-terminal 16 amino acids on NM1
functions, we generated mice lacking exon -1 of Myo1c which
contains the NM1 start codon [6]. Exon -1, and both the long and
the short arm were cloned into the pEasyFlox vector carrying
neomycin resistance and thymidyne kinase selection cassettes
together with three loxP sites (Fig 1A, 1B, 1C). The linearized
NM1 tri-loxP construct was then electroporated into the TBV2
(129S2/SvPas) ES cell line (provided by T. Ru¨licke) as follows:
TBV2 ES cells were cultured in ES cell medium (DMEM with
4.5 g/L glucose, 15% FBS, 1 mM Sodium-pyruvate, 2 mM
glutamine, 1x NEAA, 1x penicillin/streptomycin, 0.1 mM 2-
mercaptoethanol and 1000 m/ml pure leukemia inhibitory factor
(Lif)). All ingredients except Lif (Millipore) and 2-mercaptoethanol
(Sigma) were purchased from PAA. ES cells were grown on 6 mcm
plates coated with inactivated mouse embryonic fibroblasts (MEF).
Ten plates were then pooled and re-suspended in 1 mml PBS.
About 26107 cells were mixed with 30 mg linearized Myo1c
targeting construct and chilled on ice before electroporating in a
0.4 mcm electroporation cuvette using a Gene Pulser Xcell
(BioRad); (settings 500 mF and 0.23 kV). Electroporated cells were
plated onto irradiated neo-resistant MEF cells on ten 6 mcm plates.
Selection with 300 mg/ml G-418 sulphate (PAA) was started 24 mh
after electroporation. Neo-resistant colonies were picked after 14
days of G-418 treatment and screened by PCR. PCR-positive
clones were confirmed for correct targeting by Southern blot
analysis and karyotyped for euploidy. One clone was selected for
injection into C57BL/6N blastocysts.
The NM1 tri-loxP conditional mutation (Fig. 1B) was induced
in the 129/S2 genetic background. Male chimeras with more than
50% ES-derived coat color were bred with C57BL/6NCrl female
mice to test for germ-line transmission and the resulting litters with
appropriate coat color were genotyped by PCR for the targeted
mutation. Heterozygous mutants carrying the NM1 tri-loxP allele
were mated with MeuCre40 transgenic mice on C57BL/6N
background in order to excise the floxed neo and exon -1 cassettes
[29]. The resulting offspring were screened for the presence of Cre
and for the partial recombination of the NM1 tri-lox allele by PCR
(Table 1). Heterozygous NM1 knock-outs with a partial deletion
of either only the neo cassette or the complete deletion of both
exon -1 and the neo cassette were back-crossed to C57BL/6N
(Charles River Laboratories, Sulzfeld, Germany) for 5 generations.
The resulting mutants were designated as B6;129S2-
Myo1ctm1(flox)Biat for the conditional allele and B6;129S2-
Myo1ctm1.1Biat for the constitutive NM1 knock-out. For all further
experiments, mutants (KO) and wild type (WT) controls were
produced by mating heterozygous NM1 knock-out mice and their
final genotype was proven either by PCR (Fig. 1D) or western blot
with antibody specific to N-terminal domain (Fig. 1E). Mice were
housed under standard conditions, (mean room temperature
21+/21u Celsius, 40–55% relative humidity, 12:12h light-dark
cycle) and supplied with standard breeding diet (ssniff Spezialdia¨-
ten GmbH, V1126, Germany) and tap water ad libitum. Depending
on the experiment, all mice used for analysis were aged between 3
to 15 months.
Genotyping of NM1 knock-out mice
Genotypes of ES cells and mice were confirmed by PCR of
genomic DNA using consecutive primers. For identification of
targeted ES cells, P1 and P2 primers inside the neomycin-
resistance gene were used. Homologically recombined targeting
constructs were identified with P3 and P4 primers. The presence
of Cre recombinase was shown by CreF and CreR primers. Partial
recombination of the NM1 tri-lox allele, together with recognition
of full NM1 KO, WT and heterozygous mice was done by P5 and
P6 specific primers. All primers with sequences are summarized in
Table 1.
Cell culture and lentivirus work
Primary skin fibroblasts were isolated from ear explants. Skin
samples were washed in PBS and incubated with 0,3% trypsin/
PBS for 60 min in a 37uC water bath. Samples were then cut into
small pieces, placed on the bottom of Petri dish, overlaid by sterile
glass coverslip and supported by complete growth DMEM
medium with 10% FBS. Medium was changed every 3 days until
cells grew to confluence. Cells were held for a maximum of 10
passages. Stable cell lines were prepared by long-running
cultivation of primary cell culture (over 20 passages). All cell types
were grown in humidified 5% CO2/air, 37uC environment.
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For testing of interchangeability of the two myosin isoforms,
stable knock-down of human NM1 and Myo1c with exogenous
expression of mouse NM1 or Myo1c in U2OS cell line (ATCC
No. HTB-96) was prepared. U2OS cells were transduced by
pCDH-EF1-Neo carrying mouse Myo1c or NM1 and by
pLKO1.1 vector expressing shRNA targeting the sequence 59 -
GCCCGTCCAGTATTTCAACAA- 39 (Open Biosystems cat No
TRCN0000122925 AAO75-C-8). U2OS cells either stably
expressing mouse Myo1c-GFP, NM1-GFP or expressing only
the endogenous human protein were transduced with recombinant
lentiviruses expressing shRNA targeting only human cDNA. 3
days post transduction Pol I transcription rates were compared in
WT U2OS cells, U2OS cells expressing shRNA targeting human
NM1 and Myo1c and U2OS cells expressing shRNA with
exogenous expression of Myo1c-GFP or NM1-GFP by using
quantitative PCR. Recombinant lentiviruses were prepared using
second generation viral packaging system (Didier Trono Lab).
For immunoprecipitation experiments, a human H1299 cell line
(ATCC No. CRL-5803) stably expressing either NM1-Fl or
Myo1c-Fl was prepared by lentivirus transduction of pCDH-
CMV-MCS-EF1-Neo vectors carrying NM1-Fl or Myo1c-Fl
constructs.
Figure 1. Preparation of NM1 knock-out cassette. (A) WT genomic locus of Myo1c gene. Short homology arm (SA), floxed part (FP), and long
homology arm (LA) of appropriate length (0.9; 0.3; 1.7 kb respectively), were cloned to pEasyFlox vector carrying neomycin (NeoR) and thymidine
kinase (ThK) selection genes (B). Black lines represent genomic sequences; red line represents sequences derived from pEasyFlox vector. (B). (C)
Genomic loci of Myo1c gene with excision of exon -1; P1 – P6 represent different primers needed for genotyping of ES cells and knock-out mice,
yellow triangles represent loxP recombination sites. (D) Genotyping of NM1 knock-out mice by PCR. P5 and P6 primers were used to distinguish
between wild type (+/+), heterozygous (+/2) and knock-out (2/2) animals. (E) Western blot analysis of NM1 levels in NM1 wild type (+/+) and knock-
out (2/2) mice. Fifteen micrograms of protein per lane was loaded, and probed for NM1. Equal loading was monitored by Coomassie Brilliant Blue
staining of the band corresponding to actin.
doi:10.1371/journal.pone.0061406.g001
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HeLa cells (ATCC No. CCL-2) were used for defining the
protein ratio of the two isoforms in the cell nucleus and cytoplasm.
Antibodies
For western blots and immunofluorescence detection of NM1,
rabbit polyclonal antibody specific to N-terminal part of NM1
(M3456, Sigma) or rabbit polyclonal anti-NM1 antibody, which
was kindly provided by Piergiorgio Percipalle [20] were used.
Polyclonal antibody (R2652) against the tail domain of Myo1c was
kindly supplied by Peter G. Gillespie, Oregon Hearing Research
Center and Vollum Institute [30]. All other antibodies used in this
study are commercially available: antibody against b-actin (A2066)
was purchased from Sigma, anti-GAPDH antibody (clone 6G5) is
available from Acris antibodies, anti-FLAG tag antibody (200471)
from Stratagene, and anti-RNA polymerase II CTD phospho S2
(H5; ab24758) from Abcam.
Quantification of NM1/Myo1c ratio using LI-COR
Odyssey system
To explore the ratio between both isoforms in the cell nucleus
and cytoplasm in HeLa cells, LI-COR Odyssey fluorescent
detection system was used. A polyclonal antibody to the N-
terminus and a monoclonal antibody that was generated against
the tail domain of NM1/Myo1c (described above) were coupled to
infrared dyes IRDye 680 and IRDyeH 800CW (LI-COR), which
enables quantification of fluorescent signal in two separate
channels. To normalize the signal from the two antibodies, we
transfected cells with a NM1-GFP construct that has the molecular
weight of 170 kDa.
Immunoprecipitation of NM1-Fl and Myo1c-Fl
H1299 cell line stably expressing NM1-Flag or Myo1c-Flag was
prepared by lentivirus transduction. For the experiment cells were
washed with PBS and extracted with buffer containing 50 mM
HEPES pH 8, 300 mM NaCl, 4 mM MgCl2 and 1% Triton X-
100 and sonicated. Extract was cleared by centrifugation and
filtered through 0.45 mm filter. Clear lysate was incubated 2 hours
with 15 ml of pre-equilibrated Flag-M2 agarose (Sigma). As a
control, lysates were incubated 2 hours with control IgG from pre-
immune serum cross-linked to protein G-agarose beads. After the
incubation beads were washed 3 times with buffer containing
50 mM HEPES pH 8, 300 mM NaCl and 4 mM MgCl2. Finally,
the bound proteins were boiled for 5 min into SDS-PAGE loading
buffer and analyzed by SDS-PAGE.
Phenotyping of mice
A broad phenotype analysis of 50 wild type littermates as
controls (29 males, 21 females) and 46 NM1 knock-out mice (27
males, 19 females) was done in collaboration with the German
Mouse Clinic (Helmholtz Zentrum Mu¨nchen-Deutsches For-
schungszentrum fu¨r Gesundheit und Umwelt (GmbH), Neuher-
berg, Germany). Mice, 9–18 weeks old, were analyzed for
irregularities in dysmorphology, behavior, neurology, nociception,
eye function, energy metabolism, clinical chemistry and hematol-
ogy, immunology, allergy reaction, steroid metabolism, cardiovas-
cular and lung function, and pathology according to standardized
protocols [31,32].
Bone density analysis. After anesthesia, the weight and
length of the mouse were recorded, and the mouse was placed in
the pDEXA Sabre X-ray Bone Densitometer (Norland Medical
Systems. Inc., Basingstoke, Hampshire, UK). After a scout scan,
the area of interest was optimized and the measurement scan
started using following settings: scan speed 20 mm/s, resolution
0.5 mm61.0 mm, and HAW 0.020. The standard analysis
comprises a whole body analysis as well as a whole body analysis
excluding the skull. Analysis of quantitative data sets was carried
out using StatView software package (SAS Corporation).
Hematology analysis. To investigate the peripheral blood
cell count, a blood volume of about 50 ml EDTA-blood was used
to measure basic hematological parameters with a blood analyzer,
which has been validated for the analysis of mouse blood using the
laboratory mouse chip card (ABC-Blutbild-Analyzer, Scil Animal
Care Company GmbH; Viernheim, Germany). Number and size
of red blood cells were measured by electrical impedance, and
hemoglobin by spectrophotometry. Mean corpuscular volume
(MCV) was calculated directly from the cell volume measure-
ments. The hematocrit (HCT) was assessed by multiplying the
MCV with the red blood cell count. Mean corpuscular hemoglo-
bin (MCH) and mean corpuscular hemoglobin concentration
(MCHC) were calculated from hemoglobin/red blood cell count
and hemoglobin/hematocrit respectively. Data were statistically
analyzed using an R-Script, applying ANOVA (testing effects of
genotype, sex and the interaction of both) and subsequent pair-
wise comparisons using the Tukey post hoc test, and the Wilcoxon
Rank Sum Test on genotype differences separately for each sex
and over all, with the level of significance set at p,0.05.
Pulmonary function analysis. All mice were anesthetized
by i. p. injection of ketamine (137 mg/kg body weight) and xylazin
(6.6 mg/kg body weight). After opening the trachea by a small
incision, an 18 gauge cannula was inserted and fixated by ligation.
The mice were then placed in a FinePointe RC system (Buxco
Research Systems; Wilmington, NC, USA). In a heated plethys-
mograph chamber, mice were ventilated at an average rate of 160
breaths per minute, and flow and mouth pressure and heart rate
were monitored to measure resistance and dynamic compliance.
Beginning with an initial acclimation period of three minutes, a
two-minute measurement was performed. After the resistance (R)
and compliance (Cdyn) measures, mice were transferred to a
forced pulmonary maneuvers system (Buxco Research Systems;
Wilmington, NC, USA). Here, the forced residual capacity (FRC)
was determined during spontaneous breathing of the mouse using
Boyle’s Law, then quasistatic pressure volume (PV) and fast flow
volume (FV) maneuvers were run three times each and averaged
to obtain all lung volume and flow parameters. The PV test uses a
slow expiration phase after inflating the mouse to total lung
capacity (TLC) to obtain quasistatic chord compliance (Cchord),
TLC, expiratory reserve volume (ERV), residual volume (RV) and
inspiratory capacity (IC). The FV test applies a fast expiration after
inflation to TLC, thereby measuring forced vital capacity (FVC),
peak expiratory flow (PEF) and forced expiratory volume at
100 ms (FEV100).
Measurements were always performed between 8 a.m. and 1
p.m. The system was set up in a quiet room where temperature
and humidity were kept constant throughout the measurements.
Statistical analyses were performed using R-scripts implemented in
the database (MausDB). Differences between genotypes were
evaluated by Wilcoxon test. Statistical significance was assumed at
p,0.05. Data are presented as mean values6standard deviation
(SD).
Cell proliferation rate
Cells were seeded on a 6-well culture plate at a 20% confluence
and left to grow for six days in full DMEM medium, and then the
number of cells was counted. For quantitative analysis of cell
viability and cell proliferation, we also used the redox indicator
dye alamarBlueH (life technologies), which yields a colorimetric
change in a response to a metabolic activity. For all the
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experiments primary as well as stable skin fibroblast derived from
mice ear explants were used.
RNA isolation and RT-qPCR
Total RNA from cells was isolated with GeneElute Mammalian
total RNA Miniprep Kit (Sigma) according to manufacturer’s
protocol. The cells were lysed directly on cultivation plates.
Concentration of RNA was measured by spectrophotometry and
the integrity of RNA was checked on an agarose gel. 50 ng of total
RNA was reverse transcribed and single-step real-time qPCR was
performed with TaqManH Reverse Transcription Reagents and
PowerSYBRH Green PCR Master Mix (Applied Biosystems,
Roche). RT-qPCR was performed in ABI Prism 7300 instrument
(Applied Biosystems). For detection of mRNA of Myo1c and 45S
pre-rRNA and GAPDH genes, the following primers were used:
Myo1c CGATCACCCGAAGAACCA and GCGCTCTCC-
ATGGTCACT, 45S pre-rRNA GGAGTGGGGGGTGGCCGG
and GGGGAGAGGAGCAGACGAG, and GAPDH GGAAG-
GGCTCATGACCACAG and GCCATCCACAGTCTTCT-
GGG. Expression levels of 45S pre-rRNA and Myo1C were
evaluated relative to GAPDH expression level.
Results
NM1 knock-out mice are viable and fertile
Because of the different expression pattern of NM1 in different
tissues and the important roles of this protein in transcription
[6,16], chromatin remodeling [17], and chromosome movements
[33], one would assume that NM1 knock-out would have lethal
effect early during embryonic development or would have severe
developmental defects. However, NM1 KO mice were fully viable
with no significant differences from WT mice. They had a normal
number of littermates and sex rate. 320 offspring from heterozy-
gous mating have been checked: there were 157 males (49%) and
163 females (51%); 83 animals were wild type (25.9%), 159
heterozygous (49.7%) and 78 animals homozygous mutants
(24.3%); the mean litter size was 6.09 pups per litter. These data
indicate no major deviations from the expected numbers
according to the Mendelian laws suggesting normal fertility of
the heterozygous mice and viability of the homozygous mutants.
NM1 knock-out mice did not show significant differences in
weight, size or physical condition, and havent shown any obvious
behavior deviations or defects, or any pathology differences (data
not shown). 50 wild type controls (29 males, 21 females) and 46
NM1 2/2 mice (27 males, 19 females) have been analyzed for
irregularities in dysmorphology, behavior, neurology, nociception,
eye function, energy metabolism, clinical chemistry and hematol-
ogy, immunology, allergy reaction, steroid metabolism, cardiovas-
cular and lung function, and pathology in a comprehensive
phenotypic screen in cooperation with the German Mouse Clinic.
In previous experiments, Kahle et al. (2007) have determined
the expression profile of NM1 in different mouse tissues, with the
highest NM1 protein levels in the lungs. Therefore, first we
evaluated the qualitative aspects of lung function. Several
parameters have been tested in female NM1 2/2 mutants and
then compared to wild type littermates (Tidal Volume, Inspiratory
Capacity, Expiratory Reserve Volume, Vital Capacity, Functional
Residual Capacity, Total Lung Capacity, Forced Vital Capacity,
Flow Parameters, Forced Expiratory Volume, Peak Expiratory
Flow, Static Lung Compliance, Dynamic Lung Compliance, and
Lung Resistance). However, no significant genotype-specific
differences in volumetric, flow or mechanical lung function
parameters were found (Table 2). Therefore, despite high NM1
expression in lungs, the NM1 knock-out has no significant effect
on pulmonary function per se.
Further tests on NM1 knock-out evaluating deviations or
pathological changes in different screens described above did not
show any significant change between NM1 WT and KO animals
(data will be given upon request).
One group of tests evaluated bone and weight-related quanti-
tative parameters of mature mice at the age of 14 weeks. Here
NM1 2/2 male mice had significantly (p # 0.05 without
Table 2. Lung function parameters tested in NM1 knock-out and wild type mice.
Parameter Female WT Female KO p-value
n = 6 n = 6
Body Mass [g] 28.262.5 26.163.3 0.223
Volumetric Parameters
Tidal Volume [ml] 0.20360.005 0.20660.007 0.665
Inspiratory Capacity [ml] 0.8860.087 0.84160.119 0.394
Expiratory Reserve Volume [ml] 0.2760.06 0.360.04 0.294
Vital Capacity [ml] 1.1560.13 1.1460.16 0.851
Functional Residual Capacity [ml] 0.25760.028 0.26660.027 0.316
Total Lung Capacity [ml] 1.13760.094 1.10760.131 0.394
Forced Vital Capacity [ml] 1.05260.102 1.02860.156 0.394
Flow Parameters
Forced Expiratory Volume [ml] 1.02460.095 0.99960.151 0.416
Peak Expiratory Flow [ml/sec] 29.960.6 28.561.7 0.197
Mechanical Parameters
Static Lung Compliance [ml/cm H2O] 0.069460.0084 0.067860.0104 0.732
Dynamic Lung Compliance [ml/cm H2O] 0.026260.0028 0.027860.0042 0.818
Lung Resistance (R) [cm H2O/ml/sec] 1.3560.08 1.3160.09 0.563
doi:10.1371/journal.pone.0061406.t002
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correction due to multiple testing) increased bone mineral density
in comparison to wild type mice (+/+: 4564 mg/cm2, n = 10; 2/
2: 5165 mg/cm2, n = 9). Other parameters such as bone mineral
content, body weight, body length, fat and lean mass showed no
significant change or deviation in comparison to the control
littermates (Table 3). Finally, hematology screening results
indicated mild macrocytosis in mutant animals associated with a
trend towards an increased hemoglobin content in erythrocytes,
which was accompanied by slightly reduced red blood cell counts
and corpuscular hemoglobin concentration in males. Number of
red blood cells was slightly decreased (Fig. 2A), the mean
corpuscular volume (Fig. 2B) and mean corpuscular hemoglobin
(Fig. 2C) were significantly increased. This observation might
indicate impaired cell division during erythropoiesis [34].
Taken together, these data show that knock-out of NM1 gene
has no effect on mice viability and fertility, and broad phenotyping
uncovered some minor but significant changes in bone mineral
density and red blood cells parameters without any obvious
pathological defects during mice proceeding.
NM1 knock-out has no effect on cell viability,
proliferation and transcription activity
For further experiments, we prepared primary and stable
fibroblast cell lines from NM1 KO and WT mice skin explants.
These cell lines were used for evaluation of influence of NM1
deficiency at the cellular level. Typically, the condition of a cell
highly correlates with the level of transcription activity. Therefore,
we examined cell proliferation and viability by measuring the
number of cells at different time points after seeding. After six days
of growing, numbers of NM1 +/+ and NM1 2/2 cells were the
same, suggesting that cell proliferation and viability in NM1 KO
cells was not affected (Fig. 3A). We also performed alamarBlueH
assay to measure proliferation rate by colorimetric change in a
response to a metabolic activity of the cells. The data re-confirmed
the observations from the proliferation assay (data not shown).
Because of described functions of NM1 in RNA Pol I
transcription, we directly explored whether NM1 knock-out has
some effect on this process. We isolated RNA from NM1 WT and
KO skin fibroblasts in the exponential growth phase, and
measured the overall level of 45S pre-rRNA expression by RT-
qPCR. NM1 knock-out had no effect on RNA Pol I transcription
(Fig. 3B), and the expression level of 45S pre-rRNA in both cell
lines was comparable.
Considering the connection between NM1 functions in Pol I
transcription and the results described above, we can suggest that
the function of NM1 protein in knock-out mice and cell lines is
supplemented by functioning of other myosin protein or proteins.
NM1/Myo1c expression is nearly equal in tissues and cell
lines
We have previously shown that Myo1c protein differs from
NM1 in just the first 16 amino acids [6]. Both proteins contain an
identical NLS and both are able to enter the nucleus [24]. We
therefore asked whether Myo1c would be able to substitute for the
nucleus-related functions of NM1.
Firstly, we explored the ratio between both isoforms in the cell
nucleus and cytoplasm in HeLa cells. Because the molecular
weight of NM1 and Myo1c are very close to each other, we were
unable to separate the two isoforms efficiently enough to quantify
their amounts directly on western blots. We therefore used LI-
Figure 2. Red blood cells related phenotype in NM1 knock-out mice. (A) Comparison of red blood cell counts (RBC) between NM1 KO (2/2)
and WT (+/+) male (m) and female (f) mice. Male mice show slightly lower number of red blood cells. (B) Comparison of mean corpuscular volume
(MCV) in WT and KO animals shows increased cell volume in KO males and females. (C) NM1 KO animals have increased mean corpuscular
hemoglobin (MCH) level in comparison to WT males. Data are presented as mean +/2 SD. * p,0.1; ** p,0.05, *** p,0.01, **** p,0.001.
doi:10.1371/journal.pone.0061406.g002
Table 3. Overall body and bone parameters in NM1 knock-
out and wild type mice.
Parameter Male WT Male KO p-value
n = 10 n = 9
Bone mineral density [mg/cmˆ2] 4564 51q65 0.01
Bone mineral content [mg] 350695 286686 0.147
Bone content [%] 1.2460.31 1.0160.31 0.134
Body length [cm] 9.6860.22 9.7060.18 0.835
Body weight [g] 28.0761.34 28.2860.93 0.703
Fat Mass [g] 2.7362.01 2.1361.28 0.459
Lean Mass [g] 19.5962.43 20.2262.15 0.564
doi:10.1371/journal.pone.0061406.t003
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COR Odyssey fluorescent detection system that enables
quantification of fluorescent signal in two separate channels. The
intensities of NM1 and Myo1c were compared in the cytosolic and
nuclear extracts of HeLa cells. We found that in this cell line, the
ratio between NM1 and Myo1c was nearly 1:1 in both cellular
compartments (Fig. 4A). To confirm this result, we used NM1
knock-out skin fibroblasts in which the expression of NM1 is
ablated and only Myo1c is expressed. We compared the level of
total protein NM1+Myo1c using western blot. In KO cells, we
observed about 50% reduction of signal intensity as compared to
the wild type cells (Fig. 4B). Similar reduction in fluorescent
signal was observed using immunofluorescent labeling with an
antibody against NM1/Myo1c (data not shown). We also repeated
the quantification of NM1 and Myo1c using lungs and stomach
tissues from NM1 KO in comparison to WT ones. Here the ratio
of NM1 versus Myo1c was shifted more toward the Myo1c (,55%
in lungs, ,64% in stomach tissue); (Fig. 4C).
Taken together, in cell types such as the primary fibroblasts and
immortal cell lines, the NM1 isoform comprises about 50% of total
NM1+Myo1c, while the ratio appears to be shifted toward the
Myo1c isoform in mouse lungs and stomach (Fig. 4D).
Myo1c is able to functionally substitute NM1
Since the cellular distribution and expression levels of NM1 and
Myo1c are similar, we also explored the possible functional
similarities between these isoforms. Previous experiments showed
that NM1 depletion decreased RNA polymerase I transcription
rate [16]. To test whether Myo1c is able to functionally substitute
NM1 in RNA pol I transcription, we used shRNA mediated
depletion of NM1/Myo1c in U2OS cells. After decreasing Pol I
transcription rate, we were able to reconstitute the phenotype by
overexpressing mouse Myo1c that was resistant to the RNAi.
Overepression of Myo1c similarly to restored Pol I transcription
rate back to almost endogenous level in RNAi depleted cells
(Fig. 5A). Moreover, NM1 was found to be a component of Pol II
transcription machinery and was found to bind to Pol II [6]. We
already showed that Myo1c appears to have the same function in
Pol I transcription as NM1. To prove if Myo1C would also mimic
the function of NM1 with Pol II, we explored possible interacting
partners which would belong to molecular components of Pol II
transcriptional complex. When immunoprecipitating NM1 or
Myo1c proteins tagged with Flag-tag, we succeeded in co-
precipitating the CTD domain of Pol II (Fig. 5B). This together
with previous results showing no significant differences in cell
proliferation and viability in NM1 KO cells suggests a role for
Myo1c also in Pol II transcription.
Knock-out of NM1 protein has no effect on Myo1c
expression
In a previous experiment, we claimed that Myo1c seems to be
able to functionally substitute NM1 in Pol I transcription. To test
whether NM1 knock-out leads to a compensatory overexpression
of Myo1C, we isolated RNA from NM1 WT and KO skin
fibroblasts in the exponential phase of growth, and measured
Myo1c expression by RT-qPCR. All experiments were done in
triplicates, and we used primers specifically amplifying just the
Myo1c coding region. However, the level of expression of Myo1c
in both cell lines was comparable (Fig. 5C). This result suggests
that the amount of Myo1C in the nucleus is sufficient to fulfill the
roles in Pol I and Pol II transcription by itself.
Taken together, Myo1c is able to compensate for the loss of
NM1. Because the amount of Myo1c is equal to NM1 and there is
no compensatory overexpression of Myo1c in NM1 KO cells, we
suggest that both isoforms are redundant to each other and can
have same functions in Pol I transcription. Moreover, Myo1C is
able to bind to CTD domain of Pol II suggesting that these
proteins also have identical roles in Pol II transcription.
Discussion
Nuclear myosin I (Myo1c isoform B), the first molecular motor
protein which has been discovered in the cell nucleus, has brought
a revolution into the myosin field. In comparison to conventional
class I myosins which were described in different functions related
to plasma membrane and cytoskeleton, endo- and exo- cytosis, cell
motility and cell spreading [35], NM1 was found to be directly
involved in processes of RNA Pol I and RNA Pol II transcription,
chromatin remodeling and chromosome movements in the cell
nucleus. Since its discovery in 1997, 5 others myosins have been
observed in the cell nucleus (myosin VI, Va, Vb, XVIb, and
Figure 3. NM1 knock-out has no effect on cell proliferation and Pol I transcription. (A) Proliferation of NM1 KO cells (NM1 2/2) is not
altered in comparison to WT cells (NM1 +/+). 16105 cells were seeded on plates (20% confluence; day 0) and let to grow for six days when number of
cells was counted again (day 6). (B) Pol I transcription rate in NM1 KO (NM1 2/2) and WT (NM1 +/+) cells is equal. RNA from exponentially growing
cells was isolated and expression of 45S pre-rRNA was measured by RT-qPCR. Expression of 45S pre-rRNA is compared relatively to GAPDH
expression. Data are presented as mean +/2 SD.
doi:10.1371/journal.pone.0061406.g003
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Figure 4. Ratio between NM1 and Myo1c is nearby equal. (A) HeLa cells were fractionated into cytosolic and nuclear fractions. NM1 and
Myo1c amounts were quantified using double fluorescent labeling of western blot membranes after normalization to NM1-GFP band. (B) Total
amounts of NM1+Myo1c were compared in mouse skin fibroblasts derived from NM1 knock-out and NM1 wild type mouse. Beta actin signal was
used as loading normalizer. (C) Total amounts of NM1+Myo1c were compared in lungs and stomach from NM1 knock out and NM1 wild type mouse.
GAPDH signal was used as loading normalizer. (D) The graph shows the amount of NM1 and Myo1c after densitometric quantification of bands from
figures 4B and 4C showing the ratio between NM1 and Myo1c as compared to actin/GAPDH expression.
doi:10.1371/journal.pone.0061406.g004
Figure 5. Myo1C is able to function in Pol I and Pol II transcription without changes in its expression level. (A) The level of nascent
rRNA was decreased to 80% of WT levels in NM1/Myo1c knock-down cells (U2OS+C8). An overexpression of mouse NM1 (U2OS+C8+NM1) or Myo1c
(U2OS+C8+M1c) resistant to shRNA causes restoration of Pol I transcription to almost endogenous levels. As a negative control were used U2OS cells
with transduced empty pLKO1.1 vector (U2OS+NC). (B) Both NM1-Flag and Myo1c-Flag interact with Pol II. Extracts from cells overexpressing NM1-
Flag and Myo1c-Flag were co-immunoprecipitated with Flag antibody and control IgG. Immunoprecipitates were analyzed by western blotting with
antibodies against Flag, Pol II CTD subunit and Myo1c (tail domain recognizing both NM1 and Myo1c). (C) NM1 knock-out does not cause
compensatory changes in expression of Myo1c. Expression of Myo1c was measured by RT-qPCR and compared relative to GAPDH expression. Data
are presented as mean +/2 SD. *** p,0.001.
doi:10.1371/journal.pone.0061406.g005
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XVIIIb); [36]. Recently, a new isoform of human myosin 1c
protein-isoform A-was discovered and found to localize to the
nucleus. Similar to NM1, this isoform contains a unique N-
terminal peptide sequence and co-localizes with RNA polymerase
in the nucleoplasm. However, unlike NM1, upon exposure to
inhibitors of RNA polymerase II transcription, the newly identified
isoform translocates to nuclear speckles. Furthermore, in contrast
to NM1, this new isoform is absent from nucleoli and does not co-
localize with RNA polymerase I [7].
We showed previously that the ‘‘cytoplasmic’’ Myo1c protein
(isoform C) is also able to localize to the nucleus in the same
manner as the other isoforms via NLS signal localized in the
middle part of molecule [24]. To test the influence of the specific
N-terminal 16 amino acids on NM1 functions, we prepared knock-
out mice lacking the exon -1 which contains the NM1 start codon.
The resulting mRNA only contains the downstream start of
translation which gives rise to Myo1c isoform C protein.
Surprisingly, knock-out mice were without any obvious phenotype,
and proliferation assays together with RT-qPCR of 45S pre-rRNA
did not show any differences or aberrance in RNA Pol I and Pol II
transcription. This could be explained by compensatory expres-
sion of other myosin motor protein, acting in transcription, or by
the fact that the overall level of myosin motor proteins in the
nucleus is redundant and therefore a depletion of one isoform does
not affect transcription. To test these hypotheses, we depleted
Myo1c isoforms from U2OS cells by shRNA in order to decrease
Pol I transcription. We then measured the reconstitution of
transcription after overexpression of mouse Myo1c that was
unsusceptible to the RNAi. Exogenously expressed Myo1c was
able to restore the Pol I transcription rate to nearly the
endogenous level, apparently compensating for the loss of NM1.
Moreover, we found that the ratio between both isoforms in the
nucleus of WT cells is equal and there is no compensatory change
in expression of Myo1c in NM1 KO cells, suggesting that Myo1c
is transported to the nucleus normally and its amount in nucleus is
sufficient to fulfill myosin functions in transcription by itself. In
conclusion, the two different isoforms (B and C) in the nucleus
seem to be redundant for effective Pol I transcription. Moreover,
Myo1c is able to bind to CTD domain of Pol II suggesting its same
role also in Pol II transcription.
However, as mentioned above, the third Myo1c isoform-
isoform A-carrying different and longer N-terminal extension has
slightly different cytoplasmic and nuclear localization in compar-
ison to NM1 [7], and we also noted previously that localization
pattern of exogenously expressed NM1 and Myo1c do not fully
overlap [24]. This could suggest different roles for each isoform,
dependent on their N-terminal extensions, but most probably
without affecting the general process of transcription by Pol I or
Pol II. Because we did not detect changes in Pol I transcription in
NM1 KO cells, it is possible that different N-terminal extensions
will have a role in a fine tuning of myosin functions under special
conditions or in specialized cell types. It would be therefore
interesting to explore these three isoforms under various stress
conditions (i.e. UV, starvation, heat shocks) and in different tissues
and cell lines. However, to come to a definitive conclusion,
conditional knock-out mouse and derived cell lines lacking all
three isoforms are needed.
Studies of NM1 function in tissue and at a whole body level did
not show any obvious deviations in comparison to WT mice.
However, we discovered minor differences in bone mineral density
of KO mice, and discovered several genes with changed
expression profiles in NM1 KO mice in relation with lipid
metabolism in adipocytes (data not shown). This could relate bone
metabolism with insulin signaling and energy metabolism as was
described previously [37,38], but the function of NM1 in this
process is not known and has to be further studied. However, it
was shown that Myo1c is highly expressed in adipocytes and is
responsible for movements of GLUT-4 containing vesicles upon
insulin stimulus [13]. Therefore we cannot exclude the possibility
that NM1 is also playing some role in these processes, but we
suppose that its function would be related to the cytoplasmic
rather than to nuclear functions. However, to support this
speculation, future biochemical analysis of pathways of the insulin
signaling in NM1 KO mice are required.
Experiments monitoring physiological changes included also
hematology analysis which revealed mild hyperchromic macrocy-
tosis of red blood cells in mutant males characterized by larger red
blood cells containing a higher amount of hemoglobin. This
phenotype suggest an impaired cell division during erythropoiesis
[34]. Although, in cell culture cell function of the cell cycle
machinery did not show a detectable effect, rate limitation
concerning proliferation might occur in vivo on a high level due
to decreased amounts of Myo1c being available in the nucleus.
This could results in mild detectable effects in hematopoiesis since
hematopoietic tissue has an extremely high proliferation rate. This
would be comparable to the effect of some missense mutations in
ribosomal protein S19, which can be associated with macrocytosis
as the only or one of some mild symptoms in the heterozygous
state in men and mice [39,40]. Another possible explanation is
that red blood cells in NM1 knock-out mice have partially
impaired linkage between plasma membrane and cytoskeleton,
and therefore they could show increased mean corpuscular
volume. This suggestion is in agreement with previous data on
different members of Myosin I family, which were shown to work
as a dynamic link between plasma membrane and cytoskeleton
[41]. In particular; class I myosins mediate membrane/cytoskel-
eton adhesion and thus they make major contribution to
membrane tension. Their study showed that class I myosins
directly control the mechanical properties of the cell membrane
and are master regulators of cellular events involving membrane
deformation. Microarray analysis from NM1 KO mice and co-
immunoprecipitation experiments, which identified mostly cyto-
plasmic and membranous proteins link NM1 to similar processes,
described for the other members of Myosin I family (Kalendova
and Venit, in preparation). However, results mentioned above
suggest some new role of NM1 on the cell membrane and in
cytoplasmic shuttling but not in nucleus/nucleolus.
In conclusion, we prepared mice lacking functional nuclear
myosin 1 protein, which has been described as a key player in Pol I
and Pol II transcription. Knock-out mice do not show any obvious
pathological phenotype, which can be explained by functioning of
‘‘cytoplasmic’’ Myo1c isoform in nucleus in general process of
transcription. Both proteins have nearly equal expression levels
and distribution in the cell and a knock-out of NM1 does not cause
any compensatory changes in Myo1c expression. Therefore, we
suggest that both isoforms are interchangeable and redundant with
each other in the cell nucleus. This data raises additional
interesting questions: What is the functional significance of the
different N-terminal regions of the myosin molecules in nuclear
and cytoplasmic processes? What are the functions of NM1 in the
cytoplasm and on plasma membrane? What is the relationship
between these isoforms in the different cell types or tissues?
Obviously, some further investigation and preparation of new tools
will be needed to understand the interplays of Myosin 1c isoforms.
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